Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...
The Indian smartwatch market has never been more exciting or more competitive. Very often, we get new options, yet one device ...
The $349 Circular Ring 2 introduces a couple of new features to the smart ring category, but it fumbles too many basics to be ...
The Hearty Soul on MSN
14 things to do (and never do) before your next doctor appointment
Most people spend more time picking an outfit for their doctor’s visit than actually preparing for it. You show up, answer ...
Masimo (Nasdaq:MASI) today announced new study findings supporting the use of its SET pulse oximetry in critically ill neonates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results